Skip to main content
SpringerLink
Log in

Atomoxetine

Various toxicities and lack of efficacy following off-label use

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Sheldon RS, et al. Atomoxetine for suppression of vasovagal syncope. Clinical Autonomic Research 33 : 23-28, No. 1, Feb 2023. Available from: URL: 10.1007/s10286-022-00905-x

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Atomoxetine. Reactions Weekly 2000, 61 (2024). https://doi.org/10.1007/s40278-024-54750-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-024-54750-8

Search

Navigation